Registry of Lobbyists
Total Number of Communication Reports: 3
Monthly communication reports in the last 6 months: 0
| Subject matters | Details | Categories |
|---|---|---|
|
Health, Industry, Intellectual Property
|
Enhancements related to intellectual property legislation, regulations and policies applicable to pharmaceuticals.
|
Regulation, Policies or Program, Legislative Proposal, Bill or Resolution
|
|
Budget, Health, Industry, Research and Development, Science and Technology
|
Enhancement to Canada's regulatory and funding environment for new medicines, including Health Canada authorizations of medicines and framework for clinical trials, health technology assessment processes, reimbursement negotiations and funding decisions.
|
Regulation
|
|
Budget, Health
|
Federally-funded Public Drug Plans, with respect to reimbursement for medicines for federal plan beneficiaries.
|
Policies or Program
|
|
Budget, Health, Research and Development
|
Implementation of the National Strategy for Drugs for Rare Diseases and the Pharmacare Act.
|
Legislative Proposal, Bill or Resolution, Policies or Program
|
|
Economic Development, Health, Industry, Intellectual Property, Research and Development, Science and Technology
|
Innovation, Science and Economic Development Canada and Innovation Agenda, Science and Technology Strategy, or other Government policy or program initiatives to support research and development activities and attract investments in Canada, including the Biomanufacturing and Life Sciences Strategy.
|
Policies or Program
|
|
Economic Development, Foreign Affairs, Health, Industry, Intellectual Property, International Trade, Research and Development
|
Issues related to U.S. pharmaceutical importation, trade and policies, including research and development, regulatory authorizations, funding of medicines, supply sources and supply chains.
|
Policies or Program
|
|
Budget, Health, Industry, Intellectual Property
|
Regulations, guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
|
Regulation, Policies or Program
|
Address:
5401 route Trans Canadienne
St-Laurent, QC H4S 1Z1
Canada
Telephone number:
514-906-9700
Lauren Fischer, Lead, Government Affairs & Policy
AbbVie Corporation is not a subsidiary of any other parent companies.
AbbVie Corporation is not a coalition.
The activities of AbbVie Corporation are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
AbbVie Corporation does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
WILLIAM DEMPSTER | Public offices held
Firm: 3Sixty Public Affairs Inc. / 3Sixty Public Affairs Inc.